What is the price target for ZY stock?
11 analysts have analysed ZY and the average price target is 2.35 USD. This implies a price decrease of -3.46% is expected in the next year compared to the current price of 2.43.
ZYMERGEN INC (ZY) Forecast, Price Target & Analyst Ratings
NASDAQ:ZY • US98985X1000
Current stock price
2.43 USD
+0.04 (+1.67%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZYMERGEN INC (ZY).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Nov 11, 2022
- Period
- Q3 / 2022
- EPS Estimate
- -$0.68
- Revenue Estimate
- 3.381M
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.35
Upside
-3.46%
From current price of $2.43 to mean target of $2.35, Based on 11 analyst forecasts
Low
$2.02
Median
$2.35
High
$2.73
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for ZY. The average price target is 2.35 USD. This implies a price decrease of -3.46% is expected in the next year compared to the current price of 2.43.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.64%
ZY was analyzed by 11 analysts. The buy percentage consensus is at 44. So analysts seem to be rather negative about ZY.
In the previous month the buy percentage consensus was at a similar level.
ZY was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-07-26 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2022-04-13 | Goldman Sachs | Maintains | Neutral |
| 2021-09-27 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-08-31 | UBS | Downgrade | Buy -> Neutral |
| 2021-08-04 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-08-04 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2021-08-04 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-08-04 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2021-08-04 | B of A Securities | Downgrade | Buy -> Underperform |
| 2021-08-04 | HSBC | Downgrade | Hold -> Reduce |
| 2021-07-06 | HSBC | Initiate | Hold |
| 2021-06-29 | William Blair | Initiate | Outperform |
| 2021-05-17 | JP Morgan | Initiate | Overweight |
| 2021-05-17 | Goldman Sachs | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Nov 11, 2022
- Period
- Q3 / 2022
- EPS Estimate
- -$0.68
- Revenue Estimate
- 3.381M
- Revenue Q2Q
- -17.17%
- EPS Q2Q
- 9.70%
- Number of Analysts
- 8
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
ZY is expected to report earnings on 11/11/2022. The consensus EPS estimate for the next earnings is -0.68 USD and the consensus revenue estimate is 3.38M USD.
Full Analyst Estimates 2022 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15.42M | 13.28M -13.88% | 16.743M 26.08% | 13.813M -17.50% | 23.814M 72.40% | 34.348M 44.24% | 52.796M 53.71% | 83.587M 58.32% | |
| EBITDA YoY % growth | -208.12M | -222.39M -6.86% | -298.06M -34.03% | -259.533M 12.93% | -277.85M -7.06% | -147.336M 46.97% | -171.593M -16.46% | -205.839M -19.96% | |
| EBIT YoY % growth | -223.32M | -241.09M -7.96% | -318.755M -32.21% | -314.135M 1.45% | -301.999M 3.86% | -204.306M 32.35% | -234.269M -14.67% | -276.686M -18.11% | |
| Operating Margin | -1,448.25% | -1,815.44% | -1,903.81% | -2,274.25% | -1,268.18% | -594.81% | -443.73% | -331.02% | |
| EPS YoY % growth | N/A | N/A | N/A | -3.00 33.88% | -2.53 15.61% | -1.07 57.89% | -1.42 -32.77% | -1.94 -36.75% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.68 9.70% | -0.66 12.59% | -0.52 25.69% | -0.56 50.78% | -1.09 -61.22% | -1.15 -73.64% | -0.16 68.32% | -0.21 62.96% | -0.29 73.58% | -0.26 77.68% |
| Revenue Q2Q % growth | 3.381M -17.17% | 3.301M 8.63% | 4.278M -10.71% | 4.903M 86.14% | 7.334M 116.91% | 7.318M 121.68% | 4.213M -1.52% | 6.932M 41.39% | 12.02M 63.90% | 10.022M 36.95% |
| EBITDA Q2Q % growth | -58.837M 0.15% | -60.279M -40.38% | -44.537M 23.55% | -45.825M 17.47% | -102.125M -73.57% | -102.001M -69.21% | -1.092M 97.55% | -5.964M 86.99% | -14.935M 85.38% | -11.649M 88.58% |
| EBIT Q2Q % growth | -68.375M 7.67% | -69.707M -9.54% | -57.901M 9.17% | -53.066M 19.27% | -109.026M -59.45% | -108.593M -55.78% | -7.272M 87.44% | -11.948M 77.48% | -20.724M 80.99% | -17.273M 84.09% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.85%
EPS Next 5 Year
9.49%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
24.75%
Revenue Next 5 Year
36.42%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ZYMERGEN INC / ZY Forecast FAQ
What is the next earnings date for ZY stock?
ZYMERGEN INC (ZY) will report earnings on 2022-11-11, after the market close.
Can you provide the consensus estimates for ZYMERGEN INC next earnings?
The consensus EPS estimate for the next earnings of ZYMERGEN INC (ZY) is -0.68 USD and the consensus revenue estimate is 3.38M USD.
What is the consensus rating for ZYMERGEN INC (ZY) stock?
The consensus rating for ZYMERGEN INC (ZY) is 43.6364 / 100 . This indicates that analysts generally have a neutral outlook on the stock.